Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
- PMID: 1852210
- DOI: 10.1038/352345a0
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Abstract
Wild-type p53 protein has many properties consistent with its being the product of a tumour suppressor gene. Although the normal roles of tumour suppressor genes are still largely unknown, it seems that they could be involved in promoting cell differentiation as well as in mediating growth arrest by growth-inhibitory cytokines. Hence, the abrogation of wild-type p53 expression, which is a common feature of many tumours, could eliminate these activities. We have now tested this notion by restoring the expression of p53 in a murine myeloid leukaemic cell line that normally lacks p53. The use of a temperature-sensitive p53 mutant allowed us to analyse cells in which the introduced p53 had either wild-type or mutant properties. Although there seemed to be no effect on differentiation, the introduction of wild-type p53 resulted in rapid loss of cell viability in a way characteristic of apoptosis (programmed cell death). The effect of wild-type p53 was counteracted by interleukin-6. Thus products of tumour suppressor genes could be involved in restricting precursor cell populations by mediating apoptosis.
Similar articles
-
Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells.Leukemia. 1995 Apr;9(4):685-92. Leukemia. 1995. PMID: 7723404
-
p53-mediated cell death: relationship to cell cycle control.Mol Cell Biol. 1993 Mar;13(3):1415-23. doi: 10.1128/mcb.13.3.1415-1423.1993. Mol Cell Biol. 1993. PMID: 8441387 Free PMC article.
-
Regulation of leukaemic cells by interleukin 6 and leukaemia inhibitory factor.Ciba Found Symp. 1992;167:80-8; discussion 88-99. doi: 10.1002/9780470514269.ch6. Ciba Found Symp. 1992. PMID: 1425020 Review.
-
The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.Blood. 1998 Aug 15;92(4):1397-405. Blood. 1998. PMID: 9694729
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
Cited by
-
Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53.Front Mol Biosci. 2022 Aug 25;9:944955. doi: 10.3389/fmolb.2022.944955. eCollection 2022. Front Mol Biosci. 2022. PMID: 36090037 Free PMC article. Review.
-
Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers.Environ Health Perspect. 1992 Nov;98:25-37. doi: 10.1289/ehp.929825. Environ Health Perspect. 1992. PMID: 1336726 Free PMC article. Review.
-
Reversible inactivation of the transcriptional function of P53 protein by farnesylation.BMC Biotechnol. 2006 May 29;6:26. doi: 10.1186/1472-6750-6-26. BMC Biotechnol. 2006. PMID: 16732889 Free PMC article.
-
The ARTS of p53-dependent mitochondrial apoptosis.J Mol Cell Biol. 2023 Mar 29;14(10):mjac074. doi: 10.1093/jmcb/mjac074. J Mol Cell Biol. 2023. PMID: 36565718 Free PMC article. Review.
-
A proinflammatory cytokine inhibits p53 tumor suppressor activity.J Exp Med. 1999 Nov 15;190(10):1375-82. doi: 10.1084/jem.190.10.1375. J Exp Med. 1999. PMID: 10562313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous